YUNIOR QUESADA JEREZ: Open Payments
NPI 1841834421 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,797 in 124 payments from 28 companies in 2025. Trend: 2023 $2,899 · 2024 $2,532 · 2025 $3,797
Food & beverage: $3,797
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $775 |
| PFIZER INC. | 18 | $403 |
| Insulet Corporation | 6 | $379 |
| ABBVIE INC. | 19 | $328 |
| Lilly USA, LLC | 8 | $220 |
| Exact Sciences Corporation | 8 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $192 |
| Novartis Pharmaceuticals Corporation | 3 | $180 |
| Dexcom, Inc. | 2 | $167 |
| Novo Nordisk Inc | 4 | $150 |
Products named: AIRSUPRA, Omnipod, QULIPTA, CAPLYTA, LEQVIO, BREZTRI, DEXCOM G7 GSS (161), NURTEC ODT.
Industry payments across FL — which companies pay providers there.
